Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 4Ovarian Neoplasms 3Stomach Neoplasms 2Solid Tumor 2Gastric Adenocarcinoma 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Two Different Treatment Methods 1Squamous Cell Carcinoma of Head and Neck 1Osteosarcoma 1Mucosal Melanoma 1Melanoma 1Immunotherapy Gastrict Cancer 1Immunotherapy 1HER-2 Negatived Gastric Cancer 1Carcinoma, Ovarian Epithelial 1Advanced Triple Negative Breast Cancer 1Advanced Metastatic Gastric Cancer 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1Advanced Gastric Cancer 1Advanced Gastric Adenocarcinoma 1Advanced Esophagus Cancer 1Adenocarcinoma of Lung 1

Interventions

apatinib 1S 1 (combination) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × HER-2 Negatived Gastric Cancer × apatinib × Clear all
NCT03950141 2019-05-15

Apatinib Combined With S-1 as Maintenance Therapy for HER-2 Negatived Gastric Cancer

Beijing Hospital

Phase 2 Unknown
30 enrolled
Gastrointestinal

HER-2 Negatived Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡